This post is from a suggested group
Global Radiofrequency Ablation Devices Market: Minimally Invasive Technology Driving Growth in Oncology, Pain Management, and Cardiology
The Radiofrequency Ablation (RFA) Devices Market is experiencing significant expansion due to the increasing adoption of RFA as a minimally invasive, tissue-sparing alternative to traditional surgery across multiple medical specialties. RFA works by using high-frequency alternating current delivered through specialized electrodes to generate localized heat, destroying targeted tissue via coagulation necrosis. This technique offers distinct advantages, including reduced patient recovery time, lower complication rates, and the ability to treat lesions in patients who are not candidates for major surgery. The most substantial market segment is Oncology, where RFA is a proven, effective therapy for treating solid tumors in the liver, lung, kidney, and bone. Its utility is particularly crucial for smaller, early-stage tumors and in cases of recurring cancer, often as an image-guided procedure. Concurrently, the use of RFA for chronic pain management, particularly…
